Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 2 clinical ...

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

Upadacitinib continued to demonstrate safety and efficacy for severe alopecia areata in adults and adolescents, according to topline data from a second study in the phase 3 UP-AA clinical ...

In the study, 45.2% and 55.0% of patients treated with Upadacitinib 15 mg and 30 mg doses, respectively, reached 80% or more ...

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...